The North America Protein A Resin Market would witness market growth of 5.5% CAGR during the forecast period (2022-2028).
Due to the high affinity & selectivity of protein A resins, 99% purity could be obtained in the most generic form. Modification in the construction of the native Protein A, like multiple binding sites and single domain multimer, results in high binding capacity, good physicochemical stability, and high specificity towards the Fc region of antibodies.
The changed components have led to the development of a highly stable and robust protein. A affinity resin, largely utilized in immunology & biotechnology researches for purification processes and downstream processing. Protein A resin is connected with various base metrics like hydrogel filled into a ceramic shell, coated polystyrene, surface-modified porous glass, cross-linked agarose, and multiple materials based on organic polymers.
Protein A chromatography resin is essential for the purification procedure. It enables stringent purity levels throughout the purification of therapeutics antibodies. For instance, it allows the elimination of impurities and decreases the host cell proteins to < 100 ppm and DNA to < 10 pg per dose.
In 2021, Mexico imported USD 5.9 billion in medical supplies and devices and a total of USD 5.2 billion in pharmaceutical goods. The 2022 budget planning of Mexico comprises a 14.6% growth in health segment resources that gives preference to first and second-level treatment for high-specialty disorders, like cancer, heart disease, and diabetes.
Government healthcare organizations account for 70-80% of all medical facilities provided throughout the nation, whereas private healthcare organizations serve nearly 25-30% of the population. This comprises the overlap between the two facilities and contains the 32 million people with accident insurance and private medical. An increase in cancer patients and improvement in the healthcare sector across the region accelerate the use and production of protein A resins, thereby leading to regional market growth.
The US market dominated the North America Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $545.3 million by 2028.The Canada market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.9% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
Due to the high affinity & selectivity of protein A resins, 99% purity could be obtained in the most generic form. Modification in the construction of the native Protein A, like multiple binding sites and single domain multimer, results in high binding capacity, good physicochemical stability, and high specificity towards the Fc region of antibodies.
The changed components have led to the development of a highly stable and robust protein. A affinity resin, largely utilized in immunology & biotechnology researches for purification processes and downstream processing. Protein A resin is connected with various base metrics like hydrogel filled into a ceramic shell, coated polystyrene, surface-modified porous glass, cross-linked agarose, and multiple materials based on organic polymers.
Protein A chromatography resin is essential for the purification procedure. It enables stringent purity levels throughout the purification of therapeutics antibodies. For instance, it allows the elimination of impurities and decreases the host cell proteins to < 100 ppm and DNA to < 10 pg per dose.
In 2021, Mexico imported USD 5.9 billion in medical supplies and devices and a total of USD 5.2 billion in pharmaceutical goods. The 2022 budget planning of Mexico comprises a 14.6% growth in health segment resources that gives preference to first and second-level treatment for high-specialty disorders, like cancer, heart disease, and diabetes.
Government healthcare organizations account for 70-80% of all medical facilities provided throughout the nation, whereas private healthcare organizations serve nearly 25-30% of the population. This comprises the overlap between the two facilities and contains the 32 million people with accident insurance and private medical. An increase in cancer patients and improvement in the healthcare sector across the region accelerate the use and production of protein A resins, thereby leading to regional market growth.
The US market dominated the North America Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $545.3 million by 2028.The Canada market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.9% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Agarose-based
- Glass/Silica-based
- Organic Polymer-based
By End Use
- Pharmaceutical & Biopharmaceutical Companies
- Academic Research Institutes
- Others
By Type
- Recombinant
- Natural
By Application
- Antibody Purification
- Immunoprecipitation
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Repligen Corporation
- PerkinElmer, Inc
- Thermo Fisher Scientific, Inc
- Merck Millipore (Merck Group)
- Genscript Biotech Corporation
- Agilent Technologies, Inc
- Abcam plc
- Novasep Holdings SAS (Azulis Capital)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Protein A Resin Market, by Product Type
1.4.2 North America Protein A Resin Market, by End Use
1.4.3 North America Protein A Resin Market, by Type
1.4.4 North America Protein A Resin Market, by Application
1.4.5 North America Protein A Resin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Protein A Resin Market
Chapter 4. North America Protein A Resin Market by Product Type
4.1 North America Agarose-based Market by Country
4.2 North America Glass/Silica-based Market by Country
4.3 North America Organic Polymer-based Market by Country
Chapter 5. North America Protein A Resin Market by End-use
5.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 North America Academic Research Institutes Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Protein A Resin Market by Type
6.1 North America Recombinant Market by Country
6.2 North America Natural Market by Country
Chapter 7. North America Protein A Resin Market by Application
7.1 North America Antibody Purification Market by Country
7.2 North America Immunoprecipitation Market by Country
Chapter 8. North America Protein A Resin Market by Country
8.1 US Protein A Resin Market
8.1.1 US Protein A Resin Market by Product Type
8.1.2 US Protein A Resin Market by End-use
8.1.3 US Protein A Resin Market by Type
8.1.4 US Protein A Resin Market by Application
8.2 Canada Protein A Resin Market
8.2.1 Canada Protein A Resin Market by Product Type
8.2.2 Canada Protein A Resin Market by End-use
8.2.3 Canada Protein A Resin Market by Type
8.2.4 Canada Protein A Resin Market by Application
8.3 Mexico Protein A Resin Market
8.3.1 Mexico Protein A Resin Market by Product Type
8.3.2 Mexico Protein A Resin Market by End-use
8.3.3 Mexico Protein A Resin Market by Type
8.3.4 Mexico Protein A Resin Market by Application
8.4 Rest of North America Protein A Resin Market
8.4.1 Rest of North America Protein A Resin Market by Product Type
8.4.2 Rest of North America Protein A Resin Market by End-use
8.4.3 Rest of North America Protein A Resin Market by Type
8.4.4 Rest of North America Protein A Resin Market by Application
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Repligen Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.3 PerkinElmer, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.6 Merck Millipore (Merck Group)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Genscript Biotech Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expenses
9.8 Agilent Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Abcam plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. Novasep Holdings SAS (Azulis Capital)
9.10.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Repligen Corporation
- PerkinElmer, Inc
- Thermo Fisher Scientific, Inc.
- Merck Millipore (Merck Group)
- Genscript Biotech Corporation
- Agilent Technologies, Inc.
- Abcam plc
- Novasep Holdings SAS (Azulis Capital)
Methodology
LOADING...
